Positive Results Of Clinical Studies For Aclidinium Bromide, A Novel Long-Acting Anticholinergic For The Treatment For COPD
Added: 21 ìàÿ 2008
Last relative articles:
- O'Keefe Receives Gruber Neuroscience Prize For Discovery Of Place Cells And Their Role In Cognition
- Seminar Focuses On Quality And Safety In Nursing Education, Illinois, USA
- UO Team's Findings Could Pave Way For Synthetic Compounds Useful In Drug Discovery And Materials Science
- Former President George Bush And Barbara Bush Lead C-Change Initiative To Unify Public Education Messages On Cancer Prevention And Early Detection
- Published Study Reveals Next Pharmaceuticals' Flavoxine trade; Reduces Multiple Heart Health Risk Factors Including High Cholesterol
- AquaSlim Helps You Get The Summer You Deserve -- Drink Thin With New AquaSlim
- Market America Announces Plans To Launch Vitamins For Children With Autism
- Wedensky Modulation Identifies Sudden Cardiac Arrest Risk In Patients
- VitalCare's Patient Of The Month Program Launch
- A New Approach To Epilepsy Treatment Takes Its First Steps
Comments: [0] / Post comment:
29 Nov 2008 00:54:55
Almirall abre la puerta a nuevas compras para reforzar su ... - Expansión.com
elEconomista.es Almirall abre la puerta a nuevas compras para reforzar su ... Expansión.com, Spain - ... a causa de los resultados no tan satisfactorios como los esperados de la Fase III de su producto estrella, el bromuro de aclidinio ( Aclidinium ), ... Jorge Gallardo aboga por las fusiones farmacéuticas El presidente de Almirall aboga por que haya fusiones en la ...12 Nov 2008 10:43:38
Comentario de Mercado - Periodista Digital
Comentario de Mercado Periodista Digital, Spain - En cuanto al principal producto de su pipeline, Aclidinium Bromide, tal como ya anunció, la Compañía prevé mantener una reunión con la FDA durante el 1T09 e ...